Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Illinois Wellness Insider.
Press releases published on June 24, 2025
FreedomCare Expands Home Care Services in Illinois Through the Medicaid Home Services Program
EIN Presswire
·
June 24, 2025
FreedomCare launches In-Home Care Services in Illinois via the HSP, helping Medicaid members get trusted care from a family member or friend. CHICAGO, IL, UNITED STATES, June 24, 2025 /EINPresswire.com/ -- FreedomCare, a national leader in home-based …
Royal Cyber Hosts Agentic AI Executive Forum July 22 at Microsoft Office — Part of TechChicago Week
EIN Presswire
·
June 24, 2025
Join AI leaders on July 22 in Chicago for panels, demos …
Multiple Sclerosis Clinical Trial Pipeline Shows Potential with Active Contributions from 60+ Key Companies | DelveInsight
GlobeNewswire
·
June 24, 2025
New York, USA, June 24, 2025 (GLOBE NEWSWIRE) -- Multiple Sclerosis Clinical Trial Pipeline Shows Potential with Active Contributions from 60+ Key Companies | DelveInsight Multiple Sclerosis, the most common neurological disorder in young adults, with …
Lulutox Tea UK (Lulutox Tea Detox) Officially Launches in Ireland, USA, Australia & Canada for Natural Digestive Cleanse
GlobeNewswire
·
June 24, 2025
New York City, June 24, 2025 (GLOBE NEWSWIRE) -- Lulutox™, a rising name in wellness and herbal nutrition, is excited to announce the official launch of its flagship product, Lulutox Detox Tea, across international markets including Ireland, the United …
PETVIVO HOLDINGS, INC. ANNOUNCES CLOSE OF PURCHASE OPTION TIED TO SERIES B CONVERTIBLE PREFERRED STOCK OFFERING
GlobeNewswire
·
June 24, 2025
MINNEAPOLIS, June 24, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW) and its wholly-owned subsidiary PetVivo Animal Health, Inc. (collectively "PetVivo" or the “Company”) an emerging biomedical device company focused on the …
PruittHealth Certified as a Great Place to Work®
GlobeNewswire
·
June 24, 2025
NORCROSS, Ga., June 24, 2025 (GLOBE NEWSWIRE) -- For the fourth consecutive year, PruittHealth, a leader in the Southeast for post-acute care and senior services, is officially certified as a Great Place to Work® for 2025. This prestigious recognition …
Hapbee Delivers Breakout Q1 2025: Record Growth, Leaner Operations, and a Clear Path to Scalable Profitability
GlobeNewswire
·
June 24, 2025
VANCOUVER, British Columbia, June 24, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies Inc. (TSXV: HAPB | OTCQB: HAPBF), (“Hapbee” or the “Company”), the digital wellness technology company pioneering the science of bio-streaming, announced today its …
Inventprise Announces Breakthrough in COVID-19 Conjugate Vaccine Study Published in Vaccine Journal
GlobeNewswire
·
June 24, 2025
REDMOND, Wash., June 24, 2025 (GLOBE NEWSWIRE) -- Inventprise, a clinical stage vaccine invention company, today announced the publication of a landmark preclinical study in Vaccine Journal (Vol. 54, April 30, 2025, Article 126988) showcasing the potential …
First Steroid Cycle 2025: Experts Discuss Science Behind Beginner’s Guide to Choise Best Steroids for Muscle Growth, Bulking & Cutting By CrazyBulk
GlobeNewswire
·
June 24, 2025
New York City, June 24, 2025 (GLOBE NEWSWIRE) -- How First-Time Users Can Build Muscle with Confidence’ Ultimate Beginner’s Guide to Steroid Cycles: Safe, Legal, and Effective Alternatives for Muscle Growth and Performance in 2025 Launches By CrazyBulk. …
National Fitness Partners Raises Over $24,000 for Make-A-Wish Foundation
GlobeNewswire
·
June 24, 2025
CAMP HILL, Pa., June 24, 2025 (GLOBE NEWSWIRE) -- National Fitness Partners (NFP), a leading Planet Fitness franchisee, is proud to announce it has raised $24,121.61 in support of Make-A-Wish Foundation, helping grant life-changing wishes for children with …
Cosmos Health Enters U.S. Market with Strategic Made-in-America Manufacturing, Mitigating Tariff Risks; Executes Agreement with New Jersey-Based DolCas Biotech
GlobeNewswire
·
June 24, 2025
CHICAGO, June 24, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R…
Fortrea und Emery Pharma kündigen strategische Zusammenarbeit zur Durchführung FDA-konformer Arzneimittelwechselwirkungsstudien mit Rifampin an
GlobeNewswire
·
June 24, 2025
Durham, North Carolina, June 24, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (das „Unternehmen“), ein führendes globales Auftragsforschungsinstitut (Contract Research Organization CRO), hat heute eine strategische Zusammenarbeit mit Emery Pharma …
Fortrea et Emery Pharma annoncent une collaboration stratégique visant à mener des études sur les interactions médicamenteuses répondant aux normes de la FDA en utilisant la rifampicine
GlobeNewswire
·
June 24, 2025
DURHAM, Caroline du Nord, 24 juin 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq : FTRE) (la « Société »), une société de recherche contractuelle d’envergure mondiale (CRO) de premier plan, a annoncé aujourd’hui une collaboration stratégique avec Emery Pharma, …
Fortrea & Emery Pharma Umumkan Kolaborasi Strategis untuk Melakukan Studi Interaksi Obat-Obat yang Sesuai Peraturan FDA dengan Menggunakan Rifampin
GlobeNewswire
·
June 24, 2025
DURHAM, N.C., June 24, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (“Perusahaan”), perusahaan riset berbasis kontrak (CRO) global terkemuka, hari ini mengumumkan kolaborasi strategis dengan Emery Pharma, CRO analitik dan bioanalitik terkemuka yang …
Fortrea y Emery Pharma anuncian colaboración estratégica para realizar estudios de interacción fármaco-fármaco que cumplan con la FDA utilizando rifampicina
GlobeNewswire
·
June 24, 2025
DURHAM, Carolina del Norte, June 24, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (la "Empresa"), una organización líder mundial en investigación por contrato (CRO), anunció hoy una colaboración estratégica con Emery Pharma, una CRO analítica y …
Fortrea ו-Emery Pharma מכריזות על שיתוף פעולה אסטרטגי לביצוע מחקרי אינטראקציה בין תרופות באמצעות ריפמפיצין, בהתאם לתקני ה-FDA
GlobeNewswire
·
June 24, 2025
דורהאם, קרוליינה הצפונית, June 24, 2025 (GLOBE NEWSWIRE) -- Fortrea (נאסד"ק:FTRE) ("החברה"), חברה שהיא ארגון מחקר מבוסס חוזים (CRO) גלובלית מובילה, הודיעה היום על שיתוף פעולה אסטרטגי עם Emery Pharma, חברת CRO אנליטית וביו-אנליטית מובילה המספקת שירותי בדיקה …
Fortrea dan Emery Pharma Umumkan Kerjasama Strategik untuk Menjalankan Kajian Interaksi Ubat yang Mematuhi Piawaian FDA Menggunakan Rifampin
GlobeNewswire
·
June 24, 2025
DURHAM, N.C., June 24, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (“Syarikat”), sebuah organisasi penyelidikan kontrak (CRO) global terkemuka, hari ini mengumumkan kerjasama strategik dengan Emery Pharma, sebuah CRO analitik dan bioanalitik terkemuka …
Fortrea & Emery Pharma Anunciam Colaboração Estratégica para Fornecer Estudos de Interação Medicamentosa Usando Rifampicina em Conformidade com o FDA
GlobeNewswire
·
June 24, 2025
DURHAM, N.C., June 24, 2025 (GLOBE NEWSWIRE) -- A Fortrea (Nasdaq: FTRE) (a “Empresa”), uma organização líder global de pesquisa por contrato (CRO), anunciou hoje uma colaboração estratégica com a Emery Pharma, uma CRO analítica e bioanalítica líder que …
フォートリア (Fortrea) とエメリー・ファーマ (Emery Pharma)、リファンピンを用いたFDA準拠の薬物相互作用 (Drug-Drug-Interaction、DDI) 試験を提供するための戦略的提携を発表
GlobeNewswire
·
June 24, 2025
ノースカロライナ州ダーラム発, June 24, 2025 (GLOBE NEWSWIRE) -- グローバルな大手医薬品開発業務受託機関 (CRO) であるフォートリア (NASDAQ: FTRE)(以下「同社」) は本日、大手分析・バイオ分析CROとしてcGMPおよびGLPに準拠した試験サービスを提供するエメリー・ファーマとの戦略的提携を発表した。この提携により、薬物相互作用 (DDI) 試験で使用される主要薬剤であるリファンピンに対し、1-メチル-4-ニトロソピペラジン (MNP) …
Fortrea 與 Emery Pharma 宣佈開展戰略合作，使用利福平 (Rifampin) 開展符合 FDA 要求的藥物相互作用試驗
GlobeNewswire
·
June 24, 2025
達勒姆，北卡羅來納州, June 24, 2025 (GLOBE NEWSWIRE) -- 全球領先的受託研究機構 (CRO) Fortrea (Nasdaq: FTRE)（下稱「公司」）今天宣佈與 Emery Pharma 建立戰略合作關係。Emery Pharma 是一家領先的分析和生物分析受託研究機構，根據現行的《良好生產規範》(cGMP) 和《藥物非臨床研究品質管理規範》(GLP) 提供測試服務。Fortrea 與 Emery Pharma 的戰略合作將為藥物相互作用 (DDI) …